Clinical Trials Logo

Clinical Trial Summary

This study aims to assess whether extending the duration of caffeine therapy will help preterm infants achieve full oral feeding faster.


Clinical Trial Description

This study is a randomized, double-blinded, placebo-controlled trial. Infants will be randomized to receive either caffeine or placebo for up to maximum of four additional weeks after meeting clinical criteria to discontinue caffeine. Initiation of oral feeding will be based on standard of care as determined by a neonatal occupational therapist and clinical cues. Oral feedings will be advanced by a standardized 5 step oral feeding protocol. The time it takes to achieve full oral feeds between the treatment and control groups will be compared. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06327152
Study type Interventional
Source University of California, Irvine
Contact Rosie Magallon
Phone 714-509-6082
Email rmagallo@hs.uci.edu
Status Recruiting
Phase Phase 2
Start date February 22, 2024
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT03670732 - CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure N/A
Terminated NCT02524249 - Early Versus Late Caffeine for ELBW Newborns N/A
Completed NCT03292562 - A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation N/A
Recruiting NCT05298748 - The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants N/A
Recruiting NCT05968586 - Non-Invasive Neurally Adjusted Ventilatory Assist (NAVA) Prone vs Supine in Premature Infants N/A
Active, not recruiting NCT02641249 - Non-invasive Intervention for Apnea of Prematurity N/A
Terminated NCT01911182 - Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea Phase 2/Phase 3
Completed NCT00182312 - Caffeine for Apnea of Prematurity (CAP) Phase 3
Recruiting NCT03651648 - Apnea Treatment in Premature Infants Using an Automatic Vibro-tactile Stimulator Triggered by the Detection of Apnea-bradycardia. N/A
Recruiting NCT03298347 - Caffeine for Preterm Infants With Apnea of Prematurity(AOP) N/A
Completed NCT01020357 - Caffeine for Apnea of Prematurity-Sleep (CAP-S) Study Phase 3
Completed NCT00809055 - MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine Phase 4
Completed NCT03298035 - A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants N/A
Completed NCT03695900 - Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants N/A
Completed NCT04327466 - Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants N/A
Not yet recruiting NCT06374147 - "Prapela® SVS Incubator Pad for Apnea of Prematurity N/A
Completed NCT04868565 - Target Weaning Oxygen to Determine Cafffeine Duration for AOP Phase 4
Terminated NCT00482040 - Randomized Trial Investigating Four Nasal CPAP Systems in the Management of Apnea of Prematurity N/A
Not yet recruiting NCT06292299 - The PARS Study: Paediatric Advanced Respiratory Service Study - An Observational Diagnostic Feasibility Study
Completed NCT05393817 - Caffeine Citrate Use and Electronic Activity of the Diaphragm (EDI) Changes